RA CAPITAL MANAGEMENT, L.P., DIR, reported an open-market or private purchase at Climb Bio, Inc. involving 7111.000000 shares for an estimated $24888.50. Reported holdings after the transaction were 3403429.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
Form 4 relationship flags and nearby filing context
No officer title
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.495 to $3.50 inclusive. The Reporting Persons undertake to pr…
These securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund, L.P. (the "Nexus Fund"), RA Capital Nexus II Fund, L.P. (the "Nexus Fund II"), RA Capital Nex…
These securities are held directly by Sera.
These securities are held directly by the Nexus Fund.
These securities are held directly by the Nexus Fund II.
These securities are held directly by Nexus Fund III.
These securities are held directly by the Account.
0 other filings
0 recent txs